课题基金 / 基金详情

项目摘要

项目成果

Stewart Lebrun的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Currently, the Draize live rabbit eye test is used to distinguish consumer products and materials that are safe from those that are hazardous and can cause reversible or irreversible ocular damage. However, new laws are currently being, or are planned to be, implemented in California, the United States, and the European Union to ban the use of animals in ocular irritation testing. Despite this fact, there is currently no single nonanimal test or combination of nonanimal tests that can accurately classify ocular irritants. It is of particular concern that all nonanimal tests generally overpredict the least damaging class of ocular irritants (EPA IV and GHS nonclassified materials) and cannot determine (or determine with low sensitivity) the most extreme class (EPA I and GHS 1 irreversible/corrosive materials) for which they can have sensitivity rates as low as 50%. More importantly, none of the currently validated alternative tests can detect either reversible irritants (EPA II/III and GHS 2A/B) or those materials that cause irritation that lasts from 7 to 21 days but then clears without permanent corneal damage. This target classification represents a critical UNMET NEED for correctly informing and advising consumers and manufacturers about product safety. We have recently developed and tested a new method—the in vitro depth of injury eye irritation test (IVD EIT) to detect reversible ocular irritants with high sensitivity and specificity. The purpose of this application is to further develop the IVD EIT with the long- term goal of providing a service and/or product kit for the accurate classification of reversible ocular irritants to meet this UNMET NEED as part of a nonanimal ocular irritation testing strategy. This goal will be achieved by accomplishing the following specific aims: Aim 1 (2 months): Assess the repeatability and reproducibility of the IVD EIT by performing a repeat-measures experiment of a four-chemical test set composed of EPA I–IV chemicals to determine the number of corneas and positive controls needed to achieve high repeatability. Aim 2 (4 months): Perform a prevalidation test to assess the ability of the IVD EIT to categorize 30 test substances according to GHS and EPA classifications and further refine the prediction model. Aim 2 will specifically determine the accuracy, sensitivity, and specificity of the IVD EIT and identify any application domain limitations (the range of irritant categories and chemical/physical properties detected). If the results from Aim 2 validate and demonstrate the commercial and regulatory utility of the IVD EIT as defined by the ability to detect reversible irritants, we would then propose a phase II SBIR project. 1
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.tiv.2020.105070
发表时间: 2021-04
期刊: Toxicology in vitro : an international journal published in association with BIBRA
影响因子: --
作者: [Lebrun S, Nguyen L, Chavez S, Chan R, Le D, Nguyen M, Jester JV]
通讯作者: Jester JV
IVD EIT a Nonanimal Kit and Service for the Detection of Ocular Irritants: Phase II
  • 批准号:
    10699287
  • 项目类别:
  • 资助金额:
    $87.8万
  • 财政年份:
    2023
  • 负责人:
    Stewart Lebrun
  • 依托单位:
A Nonanimal Test Method to Determine the Ocular Safety of Consumer Products and Chemicals: Commercialization
  • 批准号:
    10546635
  • 项目类别:
  • 资助金额:
    $12.8万
  • 财政年份:
    2015
  • 负责人:
    Stewart Lebrun
  • 依托单位:
Non-Animal Test Method To Determine The Ocular Safety Of Consumer Products and Chemicals
  • 批准号:
    8906576
  • 项目类别:
  • 资助金额:
    $20.3万
  • 财政年份:
    2015
  • 负责人:
    Stewart Lebrun
  • 依托单位:
A Nonanimal Test Method to Determine the Ocular Safety of Consumer Products and Chemicals: Commercialization
  • 批准号:
    10696247
  • 项目类别:
  • 资助金额:
    $16.8万
  • 财政年份:
    2015
  • 负责人:
    Stewart Lebrun
  • 依托单位:
海外基金